Abbott Laboratories
—- Market cap
- $180.03B
- Debt
- —
- Cash
- −$8.52B
Complete market value, debt and cash evidence is required for enterprise value.
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ABT · price snapshotP/E 27.78x
$103.36Snapshot Sep 10, 2026, 4:00 PM ET
Implied fair value · at REGN's multiple
$71.1431.2% below market
3.72 ABT Annual EPS×19.12x REGN P/E=$71.14
Market $103.36Implied $71.14
REGN · price snapshotP/E 19.12x
$793.26Snapshot Sep 10, 2026, 4:00 PM ET
Implied fair value · at ABT's multiple
$1,152.5245.3% above market
41.48 REGN Annual EPS×27.78x ABT P/E=$1,152.52
Market $793.26Implied $1,152.52